patients in group 2 (76%).
The findings of this study suggest that the presence of coronary artery disease increases the risk of aortic valve replacement whether or not coronary artery grafting is performed. Myocardial revascularisation, however, seems to return patients with aortic valve and coronary artery disease to a survival curve similar to that of patients with isolated aortic valve disease.
Since 1960 when Harken et al first performed intracardiac aortic valve replacement using a caged ball prosthesis in the subcoronary position,' isolated aortic valve replacement has become well established and is routinely practised both for the relief of symptoms and to improve prognosis. The role of additional coronary artery bypass grafting in patients found to have coronary artery disease is, however, less certain. A review of the results of combined aortic valve replacement and coronary artery grafting in several centres shows more variable early mortality than that seen after isolated aortic valve replacement. 23 There are several important questions to consider in the management of patients with aortic valve disease. Firstly, in patients who have clinical evidence of important aortic valve dysfunction we need to define which group of patients should undergo coronary angiography at the time of cardiac catheterisation. The second question is the definition of the group of patients who should undergo combined valve replacement and coronary bypass sur- Accepted for publication 6 March 1989 with coronary artery disease is a good treatment for symptoms, it improves long term survival in only some patients.' It may be that only in those patients with coronary artery disease ofsimilar severity to that in patients in whom long term survival is improved will bypass grafting improve long term survival. Thirdly, what is the best surgical approach in this group of patients? Myocardial protection is made difficult both by the mass ofventricular muscle at risk during aortic cross clamping and by the presence of obstructive coronary arterial lesions. The combination of aortic valve surgery and coronary artery surgery should only be performed together if mortality and morbidity are low and there is a demonstrable long term improvement in symptoms and/or survival.
Most ofthese questions can only be investigated by the analysis of uncontrolled retrospective data. We have studied some of these questions in patients who had combined aortic valve disease and coronary artery disease. The place of surgery for isolated aortic valve disease is already well defined.
Patients and methods

PATIENTS
We reviewed the records of the 630 Of the patients who had coronary artery disease, those who underwent coronary artery bypass grafting (group 2) had more severe coronary disease (p < 0-01) and were in a worse functional state before operation (p < 0-01) than those who did not undergo coronary artery surgery (group 3). There was no significant difference, however, in preoperative left ventricular function between group 2 and group 3. Preoperative left ventricular function in the patients with coronary artery disease was not significantly different from that of patients in group 1; 23% poor, 44% moderate, and 33% good (table 2) . The overall early (within 30 days of operation) mortality for the three groups of patients was 6% for group 1, 13% for group 2, and 16% for group 3. Early mortality was significantly lower (p < 0-01) in group 1 than in group 2 and group 3. Table 3 shows the reduction in operative mortality of patients operated on more recently. The overall early mortality for patients who had cardioplegia for myocardial protection was 6-6% (4-2% (18/428) in group 1, Seven of the nine early deaths in group 2 were caused by a low cardiac output and failure to wean from cardiopulmonary bypass. Of the remaining two deaths one was caused by pancreatitis in relation to a low cardiac output state and one occurred ten days after operation in a man who had undergone aortic valve replacement and a single right coronary artery graft, and at necropsy the artery was found to be blocked.
There were nine early deaths in group 3. Seven of these were caused by low cardiac output and failure to wean from cardiopulmonary bypass. One occurred at 21 days in a patient who had persistent infection after three valve replacements for infective endocarditis, and the other was a man who underwent emergency surgery and died 21 days after operation ofmyocardial failure. There was only one early death in the 35 patients in group 3 who had single vessel disease while eight deaths occurred in the 20 patients who had two (or three) vessel disease or left main stem stenosis.
After operation, some patients required either inotropic infusions or placement of an intra-aortic Figure 1 shows the survival curves for the three groups of patients. Patients in group 1 had a significantly better outcome than patients in group 3 (p = 0 001), but not than that of patients in group 2. Of the patients with coronary artery disease, the patients who had undergone coronary artery bypass grafting (group 2) had a higher three year survival (76%) than those who did not undergo coronary. artery surgery (group 3, 62%), but the difference was not statistically significant. The survival curves for the patients who had survived for more than 30 days after operation were also analysed (fig 2) . Again, the outcome ofpatients in group 1 An evaluation of the place of coronary artery grafting in patients with combined aortic valve dysfunction and coronary artery disease should be based on age and sex matched populations ofpatients with similar aetiology and severity of aortic valve disease, with a similar degree of coronary artery disease. The two groups of patients should be operated upon during the same period of time, and the analysis should include early and late survival, symptomatic outcome, and the incidence of late complications. But such a study has not been and perhaps never will be performed.
The advisability ofroutine coronary arteriography at the time of cardiac catheterisation remains controversial. Apart from defining obstructive lesions in the coronary arterial tree it is also valuable in defining anatomy ofthe left main stem. It has been suggested, however, that routine angiography may not be necessary in patients who do not have angina'2 and it has been proposed that valve replacement may be performed safely without this preoperative investigation." Aortic stenosis was initially thought to confer some protection against the development of coronary artery disease.'" Since the introduction of coronary angiography, the reported incidence of coronary artery disease in patients with aortic valve disease has varied between 20% and 60%.'"'7 Some have suggested that coronary artery disease is only found in patients who have angina." '' Ramsdale et al, Aortic valve replacement with combined myocardial revascularisation however, in a study of patients with valvar heart disease undergoing coronary angiography found that 13% of patients with aortic valve disease and no angina had coronary artery disease.'0 The limitations of angina in predicting the presence of coronary artery disease in patients with aortic valve disease was also found by Coleman and Soloff.2' In the present series, 26% of patients who experienced angina had important coronary artery disease, compared with 13% of those who did not have angina. It has been shown that the unexpected finding of important coronary artery disease at the time of aortic valve replacement worsens the operative outcome. 22 The importance of preoperative diagnosis of coronary artery disease has been suggested in studies that examine both the influence of coronary artery disease and coronary artery surgery on the morbidity and mortality of aortic valve replacement. 25 Nunley and co-workers considered the problems of differing characteristics of patient subgroups through relative survival computations for age and sex variation.' Between 1976 and 1981 they reported an operative mortality ofonly 5%, which is similar to that reported for isolated aortic valve replacement. Their results, together with the favourable long term outcome for the combined operation group led to the recommendation of combined aortic valve and coronary artery surgery.
Factors such as the differing severity of coronary artery disease and the variation in preoperative functional state made the comparison of different patient subgroups in the present study difficult. Although patients who received cardioplegia had a lower early mortality than those who did not, this did not explain the differences seen between the three groups. However, of the patients with coronary artery disease, those who underwent coronary artery surgery had more severe coronary disease and a worse functional state before operation than those who did not undergo myocardial revascularisation. It is noteworthy that only 110% ofthe early deaths in the patients with important coronary artery disease who did not undergo bypass surgery occurred in those with single vessel disease, although they formed 640% of the group. Both groups of patients with coronary artery disease had similar requirements for inotropic support after operation and similar rates of perioperative myocardial infarction. It is probable that the inotropic requirement reflects important myocardial damage more accurately than electrocardiographic changes, which do not correlate well with more sensitive indices for myocardial infarction.2627
The optimal operative management of patients undergoing aortic valve replacement in the presence of coronary artery disease remains uncertain. This is important since operative mortality is almost exclusively related to myocardial infarction, which is a direct reflection of myocardial protection. It has been suggested that distal obstructions of coronary arteries should be bypassed early in the procedure to allow protection of myocardium beyond the stenoses. 
